Trials / Sponsors / Apeptico Forschung und Entwicklung GmbH
Apeptico Forschung und Entwicklung GmbH
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeab ARDS | Phase 2 | 2018-05-23 |
| Completed | Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After PGD Primary Graft Dysfunction | Phase 2 | 2013-06-01 |
| Completed | Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP30 Acute Lung Injury | Phase 2 | 2012-07-01 |